Literature DB >> 22884673

Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward.

William Stokes1, Richard McFarland, Jodie Kulpa-Eddy, Donna Gatewood, Robin Levis, Marlies Halder, Gayle Pulle, Hajime Kojima, Warren Casey, Alexander Gaydamaka, Timothy Miller, Karen Brown, Charles Lewis, Jean-Michel Chapsal, Lukas Bruckner, Sunil Gairola, Elisabeth Kamphuis, Charles E Rupprecht, Peter Wunderli, Lorraine McElhinney, Fabrizio De Mattia, Koichiro Gamoh, Richard Hill, David Reed, Vivian Doelling, Nelson Johnson, David Allen, Lori Rinckel, Brett Jones.   

Abstract

Potency testing of most human and veterinary rabies vaccines requires vaccination of mice followed by a challenge test using an intracerebral injection of live rabies virus. NICEATM, ICCVAM, and their international partners organized a workshop to review the availability and validation status of alternative methods that might reduce, refine, or replace the use of animals for rabies vaccine potency testing, and to identify research and development efforts to further advance alternative methods. Workshop participants agreed that general anesthesia should be used for intracerebral virus injections and that humane endpoints should be used routinely as the basis for euthanizing animals when conducting the mouse rabies challenge test. Workshop participants recommended as a near-term priority replacement of the mouse challenge with a test validated to ensure potency, such as the mouse antibody serum neutralization test for adjuvanted veterinary rabies vaccines for which an international collaborative study was recently completed. The workshop recommended that an in vitro antigen quantification test should be a high priority for product-specific validation of human and non-adjuvanted veterinary rabies vaccines. Finally, workshop participants recommended greater international cooperation to expedite development, validation, regulatory acceptance, and implementation of alternative test methods for rabies vaccine potency testing.
Copyright © 2012. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884673     DOI: 10.1016/j.biologicals.2012.07.005

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  5 in total

1.  A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody.

Authors:  Sunil Gairola; Manish Gautam; Satish Waghmare
Journal:  Hum Vaccin Immunother       Date:  2020-01-23       Impact factor: 3.452

2.  An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.

Authors:  Todd G Smith; James A Ellison; Xiaoyue Ma; Natalia Kuzmina; William C Carson; Charles E Rupprecht
Journal:  Vaccine       Date:  2013-06-03       Impact factor: 3.641

3.  Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities.

Authors:  Arnoud Akkermans; Jean-Michel Chapsal; Eliana M Coccia; Hilde Depraetere; Jean-François Dierick; Parichat Duangkhae; Sunil Goel; Marlies Halder; Coenraad Hendriksen; Robin Levis; Koraphong Pinyosukhee; Dieter Pullirsch; Gautam Sanyal; Li Shi; Robert Sitrin; Dean Smith; Paul Stickings; Eriko Terao; Sylvie Uhlrich; Laura Viviani; Jim Webster
Journal:  Biologicals       Date:  2020-10-08       Impact factor: 1.856

4.  Alternative Methods to Current In Vivo Procedures to Address the 3Rs Tenet in Rabies Proficiency Testing.

Authors:  Maira Zorzan; Morgane Gourlaouen; Stefania Leopardi; Paola De Benedictis
Journal:  Viruses       Date:  2022-07-31       Impact factor: 5.818

5.  Inactivated rabies vaccines: Standardization of an in vitro assay for residual viable virus detection.

Authors:  Beatriz Lourenço Correia Moreira; Ana Paula Lappas Gimenez; Jorge Minor Fernandes Inagaki; Sonia Mara Raboni
Journal:  PLoS Negl Trop Dis       Date:  2020-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.